In a groundbreaking study poised to reshape our understanding of cellular metabolism and disease pathology, scientists from Bielefeld University and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin have identified a critical regulatory mechanism that governs lysosome function in human cells. Published recently in the esteemed journal Nature Communications, this research elucidates how the protein TBC1D9B acts as a molecular “off switch” for ARL8B, a central GTPase regulator that controls lysosomal positioning and activity. These insights offer promising new avenues for therapeutic strategies targeting neurodegenerative diseases and cancer.
Lysosomes, often described as the recycling centers of the cell, perform essential roles in metabolic control by degrading damaged proteins and macromolecules into their basic constituents. Beyond this degradative role, lysosomes are instrumental in determining a cell’s fate — balancing growth signals with energy conservation pathways. Their dynamic positioning within the cell is integral to their function, yet the molecular details of how this spatial organization is regulated have remained elusive — until now.
At the core of this discovery is the GTPase protein ARL8B, which operates as a molecular switch to mobilize lysosomes along cellular microtubules toward the cell periphery. This migration enhances cellular growth and signaling activities. However, the mechanism by which ARL8B is inactivated, allowing lysosomes to reset to their basal state or respond to stress, had remained a mystery. The new findings reveal that TBC1D9B, a GAP (GTPase-activating protein), directly interacts with ARL8B to switch it off, thereby regulating lysosomal trafficking and function in response to cellular needs.
This regulatory process involves TBC1D9B binding to TMEM55B, a lysosomal membrane protein. The formation of this complex triggers the inactivation of ARL8B, effectively halting lysosomal movement and prompting their repositioning toward the cell center, especially during nutrient deprivation or metabolic stress. This repositioning facilitates autophagy — the cell’s self-cleaning process — intensifying the degradation and recycling of cellular components, which is vital for cell survival under adverse conditions.
Disruption of this finely tuned regulatory axis has profound implications. The researchers demonstrated that in cells lacking either TBC1D9B or TMEM55B, lysosomes become aberrantly distributed, dispersing across the cytoplasm rather than clustering in the perinuclear region. This mislocalization impairs autophagic flux, hindering the cell’s ability to respond to starvation and leading to metabolic imbalance. Such dysfunction is especially detrimental in neurons, where efficient proteostasis and cellular clearance are paramount to prevent accumulation of toxic protein aggregates.
The experimental approach combined advanced proteomics, genome editing tools such as CRISPR-Cas9, and confocal microscopy, enabling direct visualization and quantification of lysosome dynamics under varying genetic and environmental conditions. Using HeLa cell models with targeted knockout of TBC1D9B, the team visualized lysosomal markers (LAMP2) and tracked their redistribution in real-time. These high-resolution techniques uncovered the specific loss of spatial control over lysosomes in the absence of the TBC1D9B-mediated regulation of ARL8B.
Understanding this molecular pathway opens significant potential for medical intervention. Lysosomal dysfunction is implicated in a spectrum of human diseases, including neurodegenerative disorders like Alzheimer’s and Parkinson’s diseases, where defective clearance of aggregated proteins leads to neuronal death. Similarly, cancer cells exploit lysosomal systems to modulate their metabolism and survive in hostile microenvironments. Targeting the TBC1D9B-ARL8B axis could therefore provide novel strategies either to restore lysosomal function in degenerative diseases or to disrupt it in tumor cells, thereby limiting their growth.
Co-lead researchers Prof. Markus Damme and Prof. Volker Haucke emphasize the translational value of uncovering this regulatory module. By manipulating TBC1D9B activity or its interaction with TMEM55B, it may be possible to fine-tune lysosome positioning and function. This could bolster neuronal resilience against proteotoxic stress or potentiate immune responses by enhancing lysosome-mediated pathogen clearance, given immune cells’ reliance on ARL8B for trafficking and activation.
Moreover, the discovery underscores the significance of lysosome positioning, not merely their biochemical composition, in governing cellular metabolism. The spatial organization of lysosomes emerges as a critical determinant of their efficacy in responding to environmental cues and orchestrating intracellular signaling networks. This spatial regulation adds a new layer of complexity to lysosomal biology, expanding our understanding of how cellular organelles adapt and function.
The study’s authors used a multifaceted strategy to dissect this regulatory network, utilizing genetic ablation to pinpoint TBC1D9B’s role, and biochemical assays to characterize its GAP activity. Their proteomic analyses also identified TMEM55B as a vital scaffold protein facilitating the inactivation of ARL8B by TBC1D9B. The integration of these sophisticated approaches provides a comprehensive picture of lysosomal control mechanisms.
In light of these findings, future research directions may focus on developing small molecules or biologics that modulate TBC1D9B’s GAP activity or its interaction with TMEM55B. Such targeted therapies could represent a paradigm shift in treating diseases marked by lysosomal dysfunction. Additionally, further exploration of the ARL8B regulatory network may uncover additional proteins and pathways dictating lysosomal dynamics, offering a broader repertoire of therapeutic targets.
This pioneering work marks a significant advancement in cell biology, providing the missing piece in understanding how lysosomal function is intricately controlled at the molecular level. It highlights an elegant feedback system ensuring cellular adaptability and metabolic homeostasis, reinforcing lysosomes’ critical status as hubs of cellular health.
Subject of Research: Cells
Article Title: Control of lysosome function by the GTPase activating protein TBC1D9B and its binding partner TMEM55B.
News Publication Date: 14-Mar-2026
Web References: 10.1038/s41467-026-70345-y
Image Credits: Klaudia Kosieradzka, FMP, Berlin
Keywords: Lysosomes, ARL8B, TBC1D9B, TMEM55B, GTPase-activating protein, autophagy, cellular metabolism, neurodegenerative diseases, cancer, lysosomal trafficking, proteostasis, molecular biology
Tags: ARL8B GTPase regulationCancer Treatment Targetscellular growth and energy pathwayscellular metabolism and diseasecellular stress response regulationlysosomal positioning mechanismslysosome function in human cellslysosome migration and signalinglysosome-mediated metabolic controlmolecular switches in cell biologyneurodegenerative disease therapiesTBC1D9B protein role
